搜尋結果
AKESO Once Skyrockets 88% as New Drug Ivonescimab Meets Primary Endpoint of Progression-free ...
AASTOCKS.com· 20 小時前... (including, without limitation, any warranty or merchantability or fitness for a particula ...
Billionaire Groupon founder Eric Lefkofsky is back with another IPO: AI health tech Tempus | ...
TechCrunch· 1 日前InnerWorkings, a supply chain startup he founded in 2001, sold to private equity in 2021 for
Why half of all workers may struggle to get weight-loss drug health insurance coverage
CNBC· 1 日前... even if they want to cover weight-loss drugs, are simply priced out of the</ ... ...
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference ...
CNBC· 1 日前The company last week released a free new tool set called the AI ...
These dividend payers helped lift the Dow to fresh heights. How you would have fared if you ...
CNBC· 1 日前On a total return basis , the Dow is up 18.6% over the ...
US FDA expands use of Bristol's cell therapy to treat rare blood cancer
Reuters· 1 日前, opens new tab said on Thursday the U.S. FDA had allowed expanded use of its cell ...
Wegovy maker Novo Nordisk sues nine spas, clinics and pharmacies over copycat drugs
Reuters· 1 日前, opens new tab said on Thursday it had sued nine more medical spas, wellness clinics and ...
Clorox and these other stocks are on the verge of marking a death cross chart pattern ...
CNBC· 1 日前A small group of stocks is on the verge of forming a< ...
Jim Cramer's top 10 things to watch in the stock market Thursday
CNBC· 1 日前Dow stock and Club name Salesforce's post-earnings plunge was accounting for the bulk of th ...
Health Care Roundup: Market Talk
The Wall Street Journal· 1 日前Find insight on Merck, AstraZeneca, Novo Nordisk, Novartis and more in the latest ...